Sonablate raises $200M in a venture round

Sonablate is an AI-powered precision medicine company that uses device to treat urological indications by utilizing HIFU technologies. The company announced a $200M venture round on August 6, 2026, from its base in Charlotte, US. Investors and valuation were not disclosed in Crunchbase's round record; Lounge adds them as they are reported. It has raised more than $100M in total venture funding.